Xilio Therapeutics, Inc. (XLO)
NASDAQ · Manufacturing · Pharmaceutical preparations
XLO price, last 12 months
Key stats
- Previous close
- $7.63
- Open
- $7.60
- Day range
- $7.51 – $7.70
- 52-week range
- $6.47 – $11.20
- Volume
- 3.9K
- Avg volume (20 days)
- 12.2K
- Market cap
- $57.0M
Performance
Technicals and fundamentals
About Xilio Therapeutics, Inc.
Xilio Therapeutics Inc is a clinical-stage biotechnology company focused on discovering and developing masked immuno-oncology (I-O) therapies to improve outcomes for people living with cancer. Leveraging its clinically validated masking technology and capabilities, the company develops I-O therapies designed to selectively activate within the tumor microenvironment to achieve durable efficacy without the severe side effects associated with systemically active I-O agents. Its integrated biology and protein engineering approach enables the design and development of potent masked biologics that are activated by tumor-specific proteases.
- Sector
- Manufacturing
- Industry
- Pharmaceutical preparations
- Listed on
- NASDAQ
- Market cap
- $57.0M